Citizens & Northern Corp’s iShares Biotechnology ETF IBB Stock Holding History

Citizens & Northern Corp’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,084	Closed	-$276K	–	125
2024 Q4	$276K	Buy	+2,084	New	+$293K	0.08%	112
2020 Q1	–	Sell	-5,495	Closed	-$662K	–	102
2019 Q4	$662K	Buy	+5,495	New	+$613K	0.33%	70
2019 Q1	–	Sell	-5,193	Closed	-$501K	–	103
2018 Q4	$501K	Buy	+5,193	New	+$551K	0.35%	74

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Citizens & Northern Corp's IBB Position: Q1 2025 in Review

Citizens & Northern Corp sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 2,084 shares — an estimated $276K sold.

Citizens & Northern Corp first reported a position in IBB in Q4 2018 and held it in 3 quarters. The position peaked at $662K in Q4 2019. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

Citizens & Northern Corp reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
Citizens & Northern Corp sold 2,084 iShares Biotechnology ETF shares in Q1 2025, an estimated $276K.
Citizens & Northern Corp first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 3 quarters.
Citizens & Northern Corp's iShares Biotechnology ETF position peaked at $662K in Q4 2019.
831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Citizens & Northern Corp's 13F filing for Q1 2025, filed 21 Apr 2025.